NASDAQ: FATE       Fate Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
97.19   -0.68 (0.69%)  96.80 - 110.45  1,132,500


Avg Volume (4 weeks):1,174,638
4 Weeks Range:84.17 - 121.16
4 Weeks Price Volatility (%):
52 Weeks Range:16.75 - 121.16
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company which develops programmed cellular immunotherapies for cancer and immune disorders. It uses pharmacologic modulators, such as small molecules, to enhance the biological properties and therapeutic function of cells ex vivo before the product candidates are administered to a patient. In other cases, it uses human induced pluripotent stem cells (iPSCs), generates a master iPSC line having preferred biological properties, and direct the fate of the iPSC line to create a clonal population.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6239  2800  512  101 

Top 10 Active Counters
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00